Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
337 Leser
Artikel bewerten:
(1)

Scivita Medical's 4K UHD Fluorescence Imaging System showcased at EAES 2023

ROME, June 21, 2023 /PRNewswire/ -- On 20 June, 2023(CET), 31st International Congress of the European Association for Endoscopic Surgery (EAES 2023) was opened at Rome, Italy. Medical technology company Scivita Medical attended EAES 2023 and showcased its 4K UHD Fluorescence Imaging System, 3D Visualization System (Booth: E36), which reflects Scivita Medical's determination to its core strategy of "globalization".

Scivita Medical@ EAES 2023

Scivita Medical@ EAES 2023

Scivita Medical is a global medical technology company for minimally invasive diagnostics, establishing R&D centres in both China and Japan. Besides, Scivita Medical has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas. The company aims to increase market penetration with excellent products and be the preferred brand trusted by doctors and patients around the world through the continuous improvement of its core technologies.

With solid in-house R&D capabilities, Scivita Medical has built a unique technology platform based on five synergistic core technologies: 4K UHD medical imaging technology, Fluorescence medical imaging technology, 3D medical imaging technology, Ultrathin Endoscopic imaging technology and Single-use Endoscopic technology. With its comprehensive portfolio of endoscope products, Scivita Medical aims to cover all types of endoscopic procedures and meet various medical needs in this field.

The 4K UHD Fluorescence Imaging System exhibited at EAES 2023 is developed by 4K UHD medical imaging technology and Fluorescence medical imaging technology from this unique technology platform. Scivita Medical 4K UHD Fluorescence combined with 3D Technology to obtain ultra-high-definition 3D images with fluorescence effect, which can be used in hepatobiliary surgery, thoracic surgery, gynecology, gastrointestinal surgery, and urology, etc.

"For us, the focus is always on the doctors and patients, for whom we want to provide optimal care. EAES 2023 is a great opportunity for Scivita Medical to talk with world-class surgeon directly, to know more about local patients. " said Michael Li, Vice President of International Marketing & Sales. "In addition, we believed through this exhibition that we are able to make more local surgeon to know us and recognize us due to the high quality of our products." Mr. Li continued.

About Scivita Medical

Founded in 2016, Scivita Medical is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on the research, development and commercialization of medical endoscopes and related products. Scivita Medical takes 'Globalization' as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, Scivita Medical has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and products candidates covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering its value of 'Clinical Focus' 'Collaborative Innovation' 'People Oriented' 'Excellence & Efficiency', Scivita Medical will continuously upgrade its core technologies, improve market penetration with excellent products, and to be the preferred brand trusted by doctors and patients around the world.

For more information, please visit: scivitamedical.com

Photo - https://mma.prnewswire.com/media/2107822/Scivita_Medical__EAES_2023.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/scivita-medicals-4k-uhd-fluorescence-imaging-system-showcased-at-eaes-2023-301857079.html

© 2023 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.